Opposing regulation of T cell function by Egr-1/NAB2 and Egr-2/Egr-3

TCR-induced NF-AT activation leads to the up-regulation of multiple genes involved in T cell anergy. Since NF-AT is also involved in T cell activation, we have endeavored to dissect TCR-induced activating and inhibitory genetic programs. This approach revealed roles for the early growth response (Eg...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of immunology Vol. 38; no. 2; pp. 528 - 536
Main Authors Collins, Sam, Lutz, Michael A, Zarek, Paul E, Anders, Robert A, Kersh, Gilbert J, Powell, Jonathan D
Format Journal Article
LanguageEnglish
Published Weinheim Wiley-VCH Verlag 01.02.2008
WILEY‐VCH Verlag
Subjects
Online AccessGet full text

Cover

Loading…
Abstract TCR-induced NF-AT activation leads to the up-regulation of multiple genes involved in T cell anergy. Since NF-AT is also involved in T cell activation, we have endeavored to dissect TCR-induced activating and inhibitory genetic programs. This approach revealed roles for the early growth response (Egr) family of transcription factors and the Egr coactivator/corepressor NGFI-A-binding protein (NAB)2 in regulating T cell function. TCR-induced Egr-1 and NAB2 enhance T cell function, while Egr-2 and Egr-3 inhibit T cell function. In this report, we demonstrate that Egr-2 and Egr-3 are induced by NF-AT in the absence of AP-1, while Egr-1 and NAB2 both require AP-1-mediated transcription. Our data suggest that Egr-3 is upstream of Egr-2, and that mechanistically Egr-2 and Egr-3 suppress Egr-1 and NAB2 expression. Functionally, T cells from Egr-2 and Egr-3 null mice are hyperresponsive while T cells from Egr-3 transgenic, overexpressing mice are hyporesponsive. Furthermore, an in vivo model of autoimmune pneumonitis reveals that T cells from Egr-3 null mice hasten death while Egr-3-overexpressing T cells cause less disease. Overall, our data suggest that just as the Egr/NAB network of genes control cell fate in other systems, TCR-induced Egr-1, 2, 3 and NAB2 control the fate of antigen recognition in T cells.
AbstractList TCR-induced NF-AT activation leads to the up-regulation of multiple genes involved in T cell anergy. Since NF-AT is also involved in T cell activation, we have endeavored to dissect TCR-induced activating and inhibitory genetic programs. This approach revealed roles for the early growth response (Egr) family of transcription factors and the Egr coactivator/corepressor NGFI-A-binding protein (NAB)2 in regulating T cell function. TCR-induced Egr-1 and NAB2 enhance T cell function, while Egr-2 and Egr-3 inhibit T cell function. In this report, we demonstrate that Egr-2 and Egr-3 are induced by NF-AT in the absence of AP-1, while Egr-1 and NAB2 both require AP-1-mediated transcription. Our data suggest that Egr-3 is upstream of Egr-2, and that mechanistically Egr-2 and Egr-3 suppress Egr-1 and NAB2 expression. Functionally, T cells from Egr-2 and Egr-3 null mice are hyperresponsive while T cells from Egr-3 transgenic, overexpressing mice are hyporesponsive. Furthermore, an in vivo model of autoimmune pneumonitis reveals that T cells from Egr-3 null mice hasten death while Egr-3-overexpressing T cells cause less disease. Overall, our data suggest that just as the Egr/NAB network of genes control cell fate in other systems, TCR-induced Egr-1, 2, 3 and NAB2 control the fate of antigen recognition in T cells.
TCR‐induced NF‐AT activation leads to the up‐regulation of multiple genes involved in T cell anergy. Since NF‐AT is also involved in T cell activation, we have endeavored to dissect TCR‐induced activating and inhibitory genetic programs. This approach revealed roles for the early growth response (Egr) family of transcription factors and the Egr coactivator/corepressor NGFI‐A‐binding protein (NAB)2 in regulating T cell function. TCR‐induced Egr‐1 and NAB2 enhance T cell function, while Egr‐2 and Egr‐3 inhibit T cell function. In this report, we demonstrate that Egr‐2 and Egr‐3 are induced by NF‐AT in the absence of AP‐1, while Egr‐1 and NAB2 both require AP‐1‐mediated transcription. Our data suggest that Egr‐3 is upstream of Egr‐2, and that mechanistically Egr‐2 and Egr‐3 suppress Egr‐1 and NAB2 expression. Functionally, T cells from Egr‐2 and Egr‐3 null mice are hyperresponsive while T cells from Egr‐3 transgenic, overexpressing mice are hyporesponsive. Furthermore, an in vivo model of autoimmune pneumonitis reveals that T cells from Egr‐3 null mice hasten death while Egr‐3‐overexpressing T cells cause less disease. Overall, our data suggest that just as the Egr/NAB network of genes control cell fate in other systems, TCR‐induced Egr‐1, 2, 3 and NAB2 control the fate of antigen recognition in T cells.
Abstract TCR‐induced NF‐AT activation leads to the up‐regulation of multiple genes involved in T cell anergy. Since NF‐AT is also involved in T cell activation, we have endeavored to dissect TCR‐induced activating and inhibitory genetic programs. This approach revealed roles for the early growth response (Egr) family of transcription factors and the Egr coactivator/corepressor NGFI‐A‐binding protein (NAB)2 in regulating T cell function. TCR‐induced Egr‐1 and NAB2 enhance T cell function, while Egr‐2 and Egr‐3 inhibit T cell function. In this report, we demonstrate that Egr‐2 and Egr‐3 are induced by NF‐AT in the absence of AP‐1, while Egr‐1 and NAB2 both require AP‐1‐mediated transcription. Our data suggest that Egr‐3 is upstream of Egr‐2, and that mechanistically Egr‐2 and Egr‐3 suppress Egr‐1 and NAB2 expression. Functionally, T cells from Egr‐2 and Egr‐3 null mice are hyperresponsive while T cells from Egr‐3 transgenic, overexpressing mice are hyporesponsive. Furthermore, an in vivo model of autoimmune pneumonitis reveals that T cells from Egr‐3 null mice hasten death while Egr‐3‐overexpressing T cells cause less disease. Overall, our data suggest that just as the Egr/NAB network of genes control cell fate in other systems, TCR‐induced Egr‐1, 2, 3 and NAB2 control the fate of antigen recognition in T cells.
Author Lutz, Michael A
Anders, Robert A
Zarek, Paul E
Kersh, Gilbert J
Collins, Sam
Powell, Jonathan D
AuthorAffiliation 3 Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA
1 The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA
2 Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
AuthorAffiliation_xml – name: 1 The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA
– name: 2 Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
– name: 3 Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA
Author_xml – sequence: 1
  fullname: Collins, Sam
– sequence: 2
  fullname: Lutz, Michael A
– sequence: 3
  fullname: Zarek, Paul E
– sequence: 4
  fullname: Anders, Robert A
– sequence: 5
  fullname: Kersh, Gilbert J
– sequence: 6
  fullname: Powell, Jonathan D
BackLink https://www.ncbi.nlm.nih.gov/pubmed/18203138$$D View this record in MEDLINE/PubMed
BookMark eNp9kMFv0zAUhy00xLrBkSvkxC3re3YcJxeksRUYmtiB7Ww57nPwlNrFbkD975eu1RgXLn6y3-ffs78TdhRiIMbeIpwhAJ_TvT_jAEoolOoFm6HkWFZY4RGbAWBV8raBY3aS8z0AtLVsX7FjbDgIFM2MXd6s1zH70BeJ-nEwGx9DEV1xW1gahsKNwT4eddti0acS59_PP_HChOXjls93q3jNXjozZHpzqKfs7vPi9uJreX3z5eri_Lq0olGqpLajCmuyznYS0VgnaiTXcd4ubQXcclCVJRAcDZBa2oY3lWwdykoKV3Nxyj7uc9djt6KlpbBJZtDr5FcmbXU0Xv_bCf6n7uNvLeQkAesp4MMhIMVfI-WNXvm8-6gJFMesFfAa2kZMYLkHbYo5J3JPQxD0zruevOsn7xP_7vnL_tIH0ROg9sAfP9D2_2l68e3qefT7_U1nojZ98lnf_eCAAqCRCmQtHgDdspd3
CitedBy_id crossref_primary_10_1007_s10753_014_0059_z
crossref_primary_10_4161_cc_10_13_15711
crossref_primary_10_15252_embr_201948904
crossref_primary_10_1371_journal_pone_0049801
crossref_primary_10_1371_journal_pone_0114384
crossref_primary_10_4049_jimmunol_181_11_7778
crossref_primary_10_2139_ssrn_4061186
crossref_primary_10_3390_biom8040135
crossref_primary_10_1016_j_ajpath_2011_01_035
crossref_primary_10_1096_fj_11_194654
crossref_primary_10_1002_eji_201242942
crossref_primary_10_1002_eji_200839313
crossref_primary_10_1016_j_molimm_2015_07_026
crossref_primary_10_1134_S000629791302003X
crossref_primary_10_1371_journal_pone_0058083
crossref_primary_10_1002_eji_201242385
crossref_primary_10_1002_jcb_24944
crossref_primary_10_1017_S1461145710000799
crossref_primary_10_1016_j_matbio_2011_03_005
crossref_primary_10_3389_fimmu_2022_1052717
crossref_primary_10_1016_j_ceca_2018_12_003
crossref_primary_10_1093_rheumatology_kew342
crossref_primary_10_3389_fimmu_2019_00184
crossref_primary_10_3390_biom10111484
crossref_primary_10_1016_j_cellsig_2020_109800
crossref_primary_10_1016_j_febslet_2012_10_040
crossref_primary_10_1016_j_isci_2022_104613
crossref_primary_10_1126_scitranslmed_aaz0316
crossref_primary_10_1084_jem_20230930
crossref_primary_10_1111_j_1600_065X_2009_00817_x
crossref_primary_10_4049_jimmunol_1203452
crossref_primary_10_1016_j_prp_2020_153259
crossref_primary_10_1038_cdd_2009_11
crossref_primary_10_1016_j_ajpath_2013_06_016
crossref_primary_10_1128_MCB_00035_19
crossref_primary_10_1038_ni_2230
crossref_primary_10_3389_fnbeh_2018_00023
crossref_primary_10_1007_s12026_009_8147_0
crossref_primary_10_1523_JNEUROSCI_1802_22_2022
crossref_primary_10_1016_j_imlet_2013_02_001
crossref_primary_10_1126_sciimmunol_adj5789
crossref_primary_10_1530_REP_17_0243
crossref_primary_10_1016_j_isci_2023_107187
crossref_primary_10_1016_j_omtn_2017_04_014
crossref_primary_10_1371_journal_pone_0098074
crossref_primary_10_1002_eji_200939662
crossref_primary_10_1182_blood_2008_10_185223
crossref_primary_10_1016_j_immuni_2012_09_012
crossref_primary_10_1073_pnas_1611286114
crossref_primary_10_1002_jcb_22690
crossref_primary_10_1002_path_4131
crossref_primary_10_1016_j_humimm_2010_10_012
crossref_primary_10_3389_fimmu_2018_00350
crossref_primary_10_3858_emm_2012_44_2_007
crossref_primary_10_1371_journal_pone_0087265
crossref_primary_10_1371_journal_pone_0122198
crossref_primary_10_1002_eji_201444991
crossref_primary_10_1073_pnas_1008848108
crossref_primary_10_1016_j_ceca_2010_02_005
crossref_primary_10_1160_TH11_07_0490
crossref_primary_10_1007_s00281_010_0197_9
crossref_primary_10_1186_s12891_016_0979_x
crossref_primary_10_1126_sciimmunol_ade5872
crossref_primary_10_3389_fimmu_2014_00262
crossref_primary_10_1016_j_bbr_2019_01_038
crossref_primary_10_1084_jem_20211574
crossref_primary_10_1016_S0213_9626_10_70008_1
crossref_primary_10_3389_fimmu_2021_704578
crossref_primary_10_1073_pnas_1705848114
crossref_primary_10_4049_jimmunol_1202106
crossref_primary_10_1016_j_molimm_2017_02_019
crossref_primary_10_1038_ncomms6225
crossref_primary_10_1093_hmg_ddq092
crossref_primary_10_3892_or_2013_2503
crossref_primary_10_1016_j_molimm_2008_09_029
crossref_primary_10_1002_hipo_20926
crossref_primary_10_1097_QAD_0000000000002259
crossref_primary_10_1371_journal_pone_0015643
crossref_primary_10_1016_j_fertnstert_2011_05_062
crossref_primary_10_2147_IJGM_S353484
crossref_primary_10_1038_s41392_021_00753_7
crossref_primary_10_1038_s42003_022_04118_w
Cites_doi 10.1128/MCB.16.7.3545
10.1073/pnas.92.15.6873
10.1128/MCB.18.7.3744
10.4049/jimmunol.173.12.7331
10.4049/jimmunol.176.2.811
10.4049/jimmunol.177.12.8301
10.1093/nar/gkg186
10.1038/ni1193
10.4049/jimmunol.172.2.964
10.1128/MCB.17.7.3714
10.1074/jbc.275.13.9749
10.1038/ni1047
10.1002/jcb.20736
10.1084/jem.185.4.731
10.1002/eji.200635883
10.1016/j.immuni.2004.08.010
10.4049/jimmunol.170.8.3945
10.1016/S0092-8674(02)00767-5
10.1038/1757
10.1016/j.clim.2006.02.004
10.1084/jem.188.4.715
10.4049/jimmunol.176.8.4740
10.1016/j.cell.2006.06.052
10.1101/sqb.1999.64.527
10.1038/nn1490
10.1006/dbio.2001.0202
10.1016/S0166-2236(98)01343-5
10.1074/jbc.273.41.26923
10.1016/S0171-2985(97)80039-3
10.1016/S1074-7613(00)80182-X
10.1074/jbc.M511079200
10.1038/371796a0
ContentType Journal Article
Copyright Copyright © 2008 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim
2008 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim 2008
Copyright_xml – notice: Copyright © 2008 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim
– notice: 2008 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim 2008
DBID FBQ
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
DOI 10.1002/eji.200737157
DatabaseName AGRIS
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList


CrossRef
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: FBQ
  name: AGRIS
  url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1521-4141
EndPage 536
ExternalDocumentID 10_1002_eji_200737157
18203138
EJI200737157
US201300857056
Genre article
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: National Cancer Institute ‐ R01CA098109–02
– fundername: NCI NIH HHS
  grantid: R01 CA 098109-02
– fundername: NCI NIH HHS
  grantid: R01 CA098109
– fundername: National Cancer Institute : NCI
  grantid: R01 CA098109 || CA
GroupedDBID ---
.3N
.55
.GA
.GJ
.HR
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
24P
31~
33P
3O-
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52U
52W
52X
53G
5GY
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABEFU
ABEML
ABHUG
ABIJN
ABJNI
ABLJU
ABPVW
ABQWH
ABWRO
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACFBH
ACGFS
ACPOU
ACPRK
ACSCC
ACXBN
ACXME
ACXQS
ADAWD
ADBBV
ADDAD
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEQTP
AEUQT
AEUYR
AFBPY
AFFNX
AFFPM
AFGKR
AFPWT
AFRAH
AFVGU
AFZJQ
AGJLS
AHMBA
AI.
AIURR
AIWBW
AJBDE
AJXKR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
AOETA
ASPBG
ATUGU
AUFTA
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMNLL
BMXJE
BNHUX
BROTX
BRXPI
BY8
CS3
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRSTM
DU5
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
FBQ
FEDTE
G-S
G.N
GNP
GODZA
H.T
H.X
HBH
HF~
HHY
HHZ
HVGLF
HZ~
IX1
J0M
J5H
JPC
KQQ
L7B
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M65
MEWTI
MK4
MRFUL
MRSTM
MSFUL
MSSTM
MXFUL
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OHT
OK1
P2P
P2W
P2X
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RGB
RIWAO
RJQFR
ROL
RWI
RX1
SAMSI
SUPJJ
SV3
UB1
UPT
V2E
VH1
W8V
W99
WBKPD
WHWMO
WIB
WIH
WIK
WJL
WOHZO
WQJ
WRC
WUP
WVDHM
WXSBR
X7M
XG1
XPP
XV2
Y6R
ZA5
ZGI
ZXP
ZZTAW
~IA
~KM
~WT
AHBTC
AITYG
HGLYW
OIG
OVD
TEORI
WIN
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c3877-e9be416ecfcb511acf361efb229dc402c2074ce0321a0e7dc828459f15453f623
IEDL.DBID DR2
ISSN 0014-2980
IngestDate Tue Sep 17 21:03:29 EDT 2024
Fri Aug 16 03:05:52 EDT 2024
Fri Aug 23 00:22:08 EDT 2024
Thu May 23 23:12:40 EDT 2024
Sat Aug 24 01:08:16 EDT 2024
Wed Dec 27 19:18:31 EST 2023
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3877-e9be416ecfcb511acf361efb229dc402c2074ce0321a0e7dc828459f15453f623
Notes http://dx.doi.org/10.1002/eji.200737157
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://doi.org/10.1002/eji.200737157
PMID 18203138
PQID 70260983
PQPubID 23479
PageCount 9
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3598016
proquest_miscellaneous_70260983
crossref_primary_10_1002_eji_200737157
pubmed_primary_18203138
wiley_primary_10_1002_eji_200737157_EJI200737157
fao_agris_US201300857056
PublicationCentury 2000
PublicationDate February 2008
PublicationDateYYYYMMDD 2008-02-01
PublicationDate_xml – month: 02
  year: 2008
  text: February 2008
PublicationDecade 2000
PublicationPlace Weinheim
PublicationPlace_xml – name: Weinheim
– name: Germany
PublicationTitle European journal of immunology
PublicationTitleAlternate Eur J Immunol
PublicationYear 2008
Publisher Wiley-VCH Verlag
WILEY‐VCH Verlag
Publisher_xml – name: Wiley-VCH Verlag
– name: WILEY‐VCH Verlag
References 2004; 21
2006; 97
1995; 92
1997; 198
2006; 36
1994; 371
1999; 22
2006; 176
2004; 5
2003; 170
1999; 64
2000; 275
1996; 16
1998; 20
2003; 31
2006; 177
1996; 12
1998; 273
2001; 232
1998; 18
2005; 280
2000; 12
1997; 185
2005; 8
2004; 173
2004; 172
1997; 17
2005; 6
2006; 120
2002; 109
1998; 188
2006; 126
15585857 - J Immunol. 2004 Dec 15;173(12):7331-8
12086671 - Cell. 2002 Jun 14;109(6):719-31
16581297 - Clin Immunol. 2006 Sep;120(3):239-46
12560487 - Nucleic Acids Res. 2003 Feb 1;31(3):911-21
16136673 - Nat Neurosci. 2005 Jul;8(7):932-40
8649813 - Oncogene. 1996 Mar 7;12(5):963-71
8668170 - Mol Cell Biol. 1996 Jul;16(7):3545-53
14973438 - Nat Immunol. 2004 Mar;5(3):255-65
15485628 - Immunity. 2004 Oct;21(4):503-13
9731539 - Nat Genet. 1998 Sep;20(1):87-91
9442390 - Immunobiology. 1997 Dec;198(1-3):179-91
9756940 - J Biol Chem. 1998 Oct 9;273(41):26923-30
16552752 - J Cell Biochem. 2006 Apr 15;97(6):1292-9
15834410 - Nat Immunol. 2005 May;6(5):472-80
14707069 - J Immunol. 2004 Jan 15;172(2):964-71
11401400 - Dev Biol. 2001 Apr 15;232(2):388-99
16923394 - Cell. 2006 Aug 25;126(4):755-66
7935840 - Nature. 1994 Oct 27;371(6500):796-9
16393964 - J Immunol. 2006 Jan 15;176(2):811-8
9705953 - J Exp Med. 1998 Aug 17;188(4):715-23
9199305 - Mol Cell Biol. 1997 Jul;17(7):3714-22
9034151 - J Exp Med. 1997 Feb 17;185(4):731-44
16708405 - Eur J Immunol. 2006 Jun;36(6):1374-85
9632757 - Mol Cell Biol. 1998 Jul;18(7):3744-51
16585567 - J Immunol. 2006 Apr 15;176(8):4740-7
10203854 - Trends Neurosci. 1999 Apr;22(4):167-73
7624335 - Proc Natl Acad Sci U S A. 1995 Jul 18;92(15):6873-7
16260776 - J Biol Chem. 2005 Dec 30;280(52):42785-93
11232329 - Cold Spring Harb Symp Quant Biol. 1999;64:527-31
12682221 - J Immunol. 2003 Apr 15;170(8):3945-53
17142725 - J Immunol. 2006 Dec 15;177(12):8301-5
10755616 - Immunity. 2000 Mar;12(3):293-300
10734128 - J Biol Chem. 2000 Mar 31;275(13):9749-57
e_1_2_8_27_2
e_1_2_8_28_2
e_1_2_8_29_2
e_1_2_8_23_2
e_1_2_8_24_2
e_1_2_8_25_2
e_1_2_8_26_2
e_1_2_8_9_2
e_1_2_8_2_2
e_1_2_8_1_2
e_1_2_8_4_2
e_1_2_8_3_2
e_1_2_8_6_2
e_1_2_8_5_2
e_1_2_8_8_2
e_1_2_8_7_2
e_1_2_8_20_2
e_1_2_8_21_2
e_1_2_8_22_2
e_1_2_8_16_2
e_1_2_8_17_2
e_1_2_8_18_2
Kirsch K. H. (e_1_2_8_32_2) 1996; 12
e_1_2_8_19_2
e_1_2_8_12_2
e_1_2_8_13_2
e_1_2_8_14_2
e_1_2_8_15_2
e_1_2_8_31_2
e_1_2_8_30_2
e_1_2_8_10_2
e_1_2_8_33_2
e_1_2_8_11_2
References_xml – volume: 109
  start-page: 719
  year: 2002
  end-page: 731
  article-title: Transcriptional mechanisms underlying lymphocyte tolerance.
  publication-title: Cell
– volume: 170
  start-page: 3945
  year: 2003
  end-page: 3953
  article-title: CD4 T cells pass through an effector phase during the process of tolerance induction.
  publication-title: J. Immunol.
– volume: 198
  start-page: 179
  year: 1997
  end-page: 191
  article-title: Coordinate expression and distinct DNA‐binding characteristics of the four EGR‐zinc finger proteins in Jurkat T lymphocytes.
  publication-title: Immunobiology
– volume: 371
  start-page: 796
  year: 1994
  end-page: 799
  article-title: Krox‐20 controls myelination in the peripheral nervous system.
  publication-title: Nature
– volume: 21
  start-page: 503
  year: 2004
  end-page: 513
  article-title: Role of LAG‐3 in regulatory T cells.
  publication-title: Immunity
– volume: 120
  start-page: 239
  year: 2006
  end-page: 246
  article-title: The induction and maintenance of T cell anergy.
  publication-title: Clin. Immunol.
– volume: 126
  start-page: 755
  year: 2006
  end-page: 766
  article-title: Multilineage transcriptional priming and determination of alternate hematopoietic cell fates.
  publication-title: Cell
– volume: 173
  start-page: 7331
  year: 2004
  end-page: 7338
  article-title: Early growth response gene‐2, a zinc‐finger transcription factor, is required for full induction of clonal anergy in CD4 T cells.
  publication-title: J. Immunol.
– volume: 8
  start-page: 932
  year: 2005
  end-page: 940
  article-title: Nab proteins are essential for peripheral nervous system myelination.
  publication-title: Nat. Neurosci.
– volume: 188
  start-page: 715
  year: 1998
  end-page: 723
  article-title: Modulation of thymic selection by expression of an immediate‐early gene, early growth response 1 (Egr‐1).
  publication-title: J. Exp. Med.
– volume: 280
  start-page: 42785
  year: 2005
  end-page: 42793
  article-title: Egr‐1 induces the expression of its corepressor nab2 by activation of the nab2 promoter thereby establishing a negative feedback loop.
  publication-title: J. Biol. Chem.
– volume: 232
  start-page: 388
  year: 2001
  end-page: 399
  article-title: The transcription factor Egr3 modulates sensory axon‐myotube interactions during muscle spindle morphogenesis.
  publication-title: Dev. Biol.
– volume: 17
  start-page: 3714
  year: 1997
  end-page: 3722
  article-title: The immediate‐early gene product Egr‐1 regulates the human interleukin‐2 receptor beta‐chain promoter through noncanonical Egr and Sp1 binding sites.
  publication-title: Mol. Cell. Biol.
– volume: 185
  start-page: 731
  year: 1997
  end-page: 744
  article-title: Induction of the early growth response (Egr) family of transcription factors during thymic selection.
  publication-title: J. Exp. Med.
– volume: 177
  start-page: 8301
  year: 2006
  end-page: 8305
  article-title: Cutting Edge: TCR‐induced NAB2 enhances T cell function by coactivating IL‐2 transcription.
  publication-title: J. Immunol.
– volume: 36
  start-page: 1374
  year: 2006
  end-page: 1385
  article-title: Persistent antigenic stimulation alters the transcription program in T cells, resulting in antigen‐specific tolerance.
  publication-title: Eur. J. Immunol.
– volume: 64
  start-page: 527
  year: 1999
  end-page: 531
  article-title: Signal integration by transcription‐factor assemblies: interactions of NF‐AT1 and AP‐1 on the IL‐2 promoter.
  publication-title: Cold Spring Harb. Symp. Quant. Biol.
– volume: 275
  start-page: 9749
  year: 2000
  end-page: 9757
  article-title: A novel activation function for NAB proteins in EGR‐dependent transcription of the luteinizing hormone beta gene.
  publication-title: J. Biol. Chem.
– volume: 92
  start-page: 6873
  year: 1995
  end-page: 6877
  article-title: Identification of NAB1, a repressor of NGFI‐A‐ and Krox20‐mediated transcription.
  publication-title: Proc. Natl. Acad. Sci. USA
– volume: 18
  start-page: 3744
  year: 1998
  end-page: 3751
  article-title: Cyclosporin A‐sensitive transcription factor Egr‐3 regulates Fas ligand expression.
  publication-title: Mol. Cell. Biol.
– volume: 176
  start-page: 811
  year: 2006
  end-page: 818
  article-title: Early growth response‐1 is required for CD154 transcription.
  publication-title: J. Immunol.
– volume: 12
  start-page: 293
  year: 2000
  end-page: 300
  article-title: Sequential involvement of NFAT and Egr transcription factors in FasL regulation.
  publication-title: Immunity
– volume: 97
  start-page: 1292
  year: 2006
  end-page: 1299
  article-title: Enhanced EGR1 activity promotes the growth of prostate cancer cells in an androgen‐depleted environment.
  publication-title: J. Cell. Biochem.
– volume: 6
  start-page: 472
  year: 2005
  end-page: 480
  article-title: Egr‐2 and Egr‐3 are negative regulators of T cell activation.
  publication-title: Nat. Immunol.
– volume: 31
  start-page: 911
  year: 2003
  end-page: 921
  article-title: Early growth response proteins (EGR) and nuclear factors of activated T cells (NFAT) form heterodimers and regulate proinflammatory cytokine gene expression.
  publication-title: Nucleic Acids Res.
– volume: 273
  start-page: 26923
  year: 1998
  end-page: 26930
  article-title: The early growth response protein (EGR‐1) regulates interleukin‐2 transcription by synergistic interaction with the nuclear factor of activated T cells.
  publication-title: J. Biol. Chem.
– volume: 16
  start-page: 3545
  year: 1996
  end-page: 3553
  article-title: NAB2, a corepressor of NGFI‐A (Egr‐1) and Krox20, is induced by proliferative and differentiative stimuli.
  publication-title: Mol. Cell. Biol.
– volume: 176
  start-page: 4740
  year: 2006
  end-page: 4747
  article-title: Early growth response gene 1 provides negative feedback to inhibit entry of progenitor cells into the thymus.
  publication-title: J. Immunol.
– volume: 20
  start-page: 87
  year: 1998
  end-page: 91
  article-title: Sensory ataxia and muscle spindle agenesis in mice lacking the transcription factor Egr3.
  publication-title: Nat. Genet.
– volume: 5
  start-page: 255
  year: 2004
  end-page: 265
  article-title: Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins.
  publication-title: Nat. Immunol.
– volume: 22
  start-page: 167
  year: 1999
  end-page: 173
  article-title: The EGR family of transcription‐regulatory factors: progress at the interface of molecular and systems neuroscience.
  publication-title: Trends Neurosci.
– volume: 12
  start-page: 963
  year: 1996
  end-page: 971
  article-title: Mader: a novel nuclear protein over expressed in human melanomas.
  publication-title: Oncogene
– volume: 172
  start-page: 964
  year: 2004
  end-page: 971
  article-title: Early growth response gene 3 regulates thymocyte proliferation during the transition from CD4 CD8 to CD4 CD8 .
  publication-title: J. Immunol.
– ident: e_1_2_8_19_2
  doi: 10.1128/MCB.16.7.3545
– ident: e_1_2_8_18_2
  doi: 10.1073/pnas.92.15.6873
– ident: e_1_2_8_9_2
  doi: 10.1128/MCB.18.7.3744
– ident: e_1_2_8_16_2
  doi: 10.4049/jimmunol.173.12.7331
– ident: e_1_2_8_12_2
  doi: 10.4049/jimmunol.176.2.811
– ident: e_1_2_8_21_2
  doi: 10.4049/jimmunol.177.12.8301
– ident: e_1_2_8_11_2
  doi: 10.1093/nar/gkg186
– ident: e_1_2_8_15_2
  doi: 10.1038/ni1193
– ident: e_1_2_8_26_2
  doi: 10.4049/jimmunol.172.2.964
– ident: e_1_2_8_13_2
  doi: 10.1128/MCB.17.7.3714
– ident: e_1_2_8_20_2
  doi: 10.1074/jbc.275.13.9749
– ident: e_1_2_8_30_2
  doi: 10.1038/ni1047
– ident: e_1_2_8_4_2
  doi: 10.1002/jcb.20736
– ident: e_1_2_8_24_2
  doi: 10.1084/jem.185.4.731
– ident: e_1_2_8_17_2
  doi: 10.1002/eji.200635883
– ident: e_1_2_8_27_2
  doi: 10.1016/j.immuni.2004.08.010
– ident: e_1_2_8_33_2
  doi: 10.4049/jimmunol.170.8.3945
– ident: e_1_2_8_23_2
  doi: 10.1016/S0092-8674(02)00767-5
– ident: e_1_2_8_25_2
  doi: 10.1038/1757
– ident: e_1_2_8_28_2
  doi: 10.1016/j.clim.2006.02.004
– ident: e_1_2_8_6_2
  doi: 10.1084/jem.188.4.715
– ident: e_1_2_8_5_2
  doi: 10.4049/jimmunol.176.8.4740
– ident: e_1_2_8_7_2
  doi: 10.1016/j.cell.2006.06.052
– volume: 12
  start-page: 963
  year: 1996
  ident: e_1_2_8_32_2
  article-title: Mader: a novel nuclear protein over expressed in human melanomas.
  publication-title: Oncogene
  contributor:
    fullname: Kirsch K. H.
– ident: e_1_2_8_29_2
  doi: 10.1101/sqb.1999.64.527
– ident: e_1_2_8_2_2
  doi: 10.1038/nn1490
– ident: e_1_2_8_3_2
  doi: 10.1006/dbio.2001.0202
– ident: e_1_2_8_1_2
  doi: 10.1016/S0166-2236(98)01343-5
– ident: e_1_2_8_10_2
  doi: 10.1074/jbc.273.41.26923
– ident: e_1_2_8_8_2
  doi: 10.1016/S0171-2985(97)80039-3
– ident: e_1_2_8_14_2
  doi: 10.1016/S1074-7613(00)80182-X
– ident: e_1_2_8_22_2
  doi: 10.1074/jbc.M511079200
– ident: e_1_2_8_31_2
  doi: 10.1038/371796a0
SSID ssj0009659
Score 2.269196
Snippet TCR-induced NF-AT activation leads to the up-regulation of multiple genes involved in T cell anergy. Since NF-AT is also involved in T cell activation, we have...
TCR‐induced NF‐AT activation leads to the up‐regulation of multiple genes involved in T cell anergy. Since NF‐AT is also involved in T cell activation, we have...
Abstract TCR‐induced NF‐AT activation leads to the up‐regulation of multiple genes involved in T cell anergy. Since NF‐AT is also involved in T cell...
SourceID pubmedcentral
proquest
crossref
pubmed
wiley
fao
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 528
SubjectTerms Activation
Animals
Early Growth Response Protein 1 - antagonists & inhibitors
Early Growth Response Protein 1 - biosynthesis
Early Growth Response Protein 1 - genetics
Early Growth Response Protein 1 - physiology
Early Growth Response Protein 2 - biosynthesis
Early Growth Response Protein 2 - deficiency
Early Growth Response Protein 2 - genetics
Early Growth Response Protein 2 - physiology
Early Growth Response Protein 3 - biosynthesis
Early Growth Response Protein 3 - deficiency
Early Growth Response Protein 3 - genetics
Early Growth Response Protein 3 - physiology
EGR
Gene Expression Regulation - immunology
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Mice, Knockout
Mice, Transgenic
NAB2
Neoplasm Proteins - antagonists & inhibitors
Neoplasm Proteins - biosynthesis
Neoplasm Proteins - genetics
Neoplasm Proteins - physiology
Receptors, Antigen, T-Cell - physiology
Repressor Proteins - antagonists & inhibitors
Repressor Proteins - biosynthesis
Repressor Proteins - genetics
Repressor Proteins - physiology
T cells
T-Lymphocytes - immunology
T-Lymphocytes - metabolism
Tolerance
Title Opposing regulation of T cell function by Egr-1/NAB2 and Egr-2/Egr-3
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Feji.200737157
https://www.ncbi.nlm.nih.gov/pubmed/18203138
https://search.proquest.com/docview/70260983
https://pubmed.ncbi.nlm.nih.gov/PMC3598016
Volume 38
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT-MwEB6xSKz2wmt3IbzWB8QttHGePgIqgkqwElCJmzd27PKQUlTaA5z4CfxGfgkzcdpSdrUS4hTFiRXb47G_iWe-AdhGg0spNI79JLOxH3EjfMGLxFcItXkUNwOrKVD45DQ56kTty_iyznNKsTCOH2L8w400o1qvScFzdd-YkIaam-sqkDxMg5iiyYlMj0DR2YQ-isjy3Eoc-VxkzZpjE-s3pmpP7UlfbN77F9z822vyLZqttqPDBfgz6ojzQrndHQ7Urn58x_H4iZ4uwnwNVdmem1tLMGPKZZhzySsfluHrSX0s_x3av-_I-avssr5LbY_CZj3LLhidCzDaO6si9cBa3f7L03PQON3b5ywvi7qAN9w1_AGdw9bFwZFfJ2nwdZilqW-EMgjqjLZaIXjLtQ2TwFjFuSg0GqeaI0ihpGQ8yJsmLTSaeFEsLEG30CL4-gmzZa80q8BMZBNVZEZksY20LfKsyJRVlidpIKwWHuyMxCTvHBeHdKzLXOIYyfEYebCKQpR5F9dJ2TnndDpbMfnHiQe_RpKVqEg0CnlpesN7mRK7mshCD1acnCffQJQU4vTyIJ2aAeMXiKJ7-kl5fVVRdRM_IoJqD5qVgP_fbNlqH49v1j5eZR2-OW8WcrbZgNlBf2g2ETIN1FalF6_VEgzX
link.rule.ids 230,315,786,790,891,1382,27957,27958,46329,46753
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1PT9swFH8aTGxc2GBjhI3hw7RbaOP8s49sKiqFdtLWStys2LG7MilFXXuAEx-Bz7hPsmc7bek2IU2cojhxHPv52b9nP_8ewAc0uKRE4zjMmEnDhGoeclpmoUSoTZO0GRllDwp3e1l7kHQu0ot7p_g9P8Riwc1qhhuvrYLbBenGkjVUX47cSfI4j9J8DZ6iyqfOqPq6JJCydHl-LE5CylmzZtnEDzRWsq_MSmumGP8LcP7tN3kfz7oJ6eQFFPOqeD-UH0ezqTxSN3-wPD6mri9hq0ar5Nh3r214oqsd2PDxK6934Fm33pl_BZ0vV9b_qxqSiY9uj_ImY0P6xG4NEDt9uiR5TVrDya_bu6jRO_5ESVGVdQJt-Gv8GgYnrf7ndljHaQhVzPI81FxqxHVaGSURvxXKxFmkjaSUlwrtU0URp9i4ZDQqmjovFVp5ScqNRW-xQfy1C-vVuNJ7QHRiMlkyzVlqEmXKgpVMGmlolkfcKB7Ax7mcxJWn4xCeeJkKbCOxaKMA9lCKohjiUCkG36jdoHVk_mkWwOFctAJ1ybZCUenx7KfILcEaZ3EAb7ygl2UgUIqjmAWQr3SBxQuWpXv1STX67ti6LUUi4uoAmk7CD_-2aHVOFzf7_5_lEJ63-91zcX7aO3sLm965xfrevIP16WSmDxBBTeV7pyS_AbHxEPk
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lj9MwEB6xi1hx4bE8NrzWB8Qt28bOwz4ubKvdwhYEW2lvJnbssiClVWkPy4mfwG_klzATpy0FhIQ4RXHiJPZ4PN_E428AnqLDZQw6x3EufRan3KlY8SqPDUJtnmbdxFvaKHw6zI9H6eA8O2_znNJemMAPsfrhRprRzNek4NPKd9akoe7jRbORXBRJVmzB1TQXnIb10ds1fxSx5YWpOI25kt2WZBMf0NmovmGUtnw5-RPe_D1s8mc429ij_k14v2xJCEP5dLCYmwP75ReSx_9o6i240WJVdhgG12244upduBayV17uws5puy5_BwavpxT9VY_ZLOS2R2mziWdnjBYGGBnPpshcst549v3rt6QzPHzOWVlXbQHvhKO4C6N-7-zFcdxmaYitkEURO2UcojpnvTWI3krrRZ44bzhXlUXv1HJEKZSVjCdl1xWVRR8vzZQn7CY8oq97sF1ParcHzKU-N5V0SmY-tb4qZSWNN57nRaK8VRE8W4pJTwMZhw60y1xjH-lVH0Wwh0LU5RgnSj16x2l5tqHyz_II9peS1ahJ1Atl7SaLz7ogejUlRQT3g5zX70CYJBIhIyg2RsDqBuLo3rxSX3xouLqJIBFRdQTdRsB__2zdG5ysTh78e5V92Hlz1NevToYvH8L1ENlCgTePYHs-W7jHCJ_m5kmjIj8AbrEPqA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Opposing+regulation+of+T+cell+function+by+Egr%E2%80%901%2FNAB2+and+Egr%E2%80%902%2FEgr%E2%80%903&rft.jtitle=European+journal+of+immunology&rft.au=Collins%2C+Sam&rft.au=Lutz%2C+Michael%E2%80%84A.&rft.au=Zarek%2C+Paul%E2%80%84E.&rft.au=Anders%2C+Robert%E2%80%84A.&rft.date=2008-02-01&rft.issn=0014-2980&rft.eissn=1521-4141&rft.volume=38&rft.issue=2&rft.spage=528&rft.epage=536&rft_id=info:doi/10.1002%2Feji.200737157&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_eji_200737157
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0014-2980&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0014-2980&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0014-2980&client=summon